Advances in the development of HIV integrase strand transfer inhibitors

被引：17
作者：
Wang, Yue [1 ]
Gu, Shuang-Xi [2 ,3 ]
He, Qiuqin [1 ]
Fan, Renhua [1 ]
机构：
[1] Fudan Univ, Dept Chem, 2005 Songhu Rd, Shanghai 200438, Peoples R China
[2] Wuhan Inst Technol, Sch Chem Engn & Pharm, Key Lab Green Chem Proc, Minist Educ, Wuhan 430205, Peoples R China
[3] Wuhan Inst Technol, Hubei Key Lab Novel Reactor & Green Chem Technol, Wuhan 430205, Peoples R China
来源：
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2021年 / 225卷
基金：
中国国家自然科学基金;
关键词：
HIV-1; integrase; Strand transfer inhibitors; Metal chelating; Resistance; ZINC-BINDING DOMAIN; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; STRUCTURAL BASIS; RALTEGRAVIR; RESISTANT; DOLUTEGRAVIR; ORGANIZATION; ELVITEGRAVIR; REPLICATION;
D O I：
10.1016/j.ejmech.2021.113787
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
HIV-1 integrase (IN) is a key enzyme in viral replication that catalyzes the covalent integration of viral cDNA into the host genome. Currently, five HIV-1 IN strand transfer inhibitors (INSTIs) are approved for clinical use. These drugs represent an important addition to the armamentarium for antiretroviral therapy. This review briefly illustrates the development history of INSTIs. The characteristics of the currently approved INSTIs, as well as their future perspectives, are critically discussed. (C) 2021 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数：10
相关论文
共 50 条
  • [31] Targeting HIV-1 integrase with strand transfer inhibitors
    Li, Yang
    Xuan, Shouyi
    Feng, Yue
    Yan, Aixia
    DRUG DISCOVERY TODAY, 2015, 20 (04) : 435 - 449
  • [32] A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection
    Zhao, Alexa Vyain
    Crutchley, Rustin D.
    Guduru, Rakesh Chowdary
    Ton, Kathy
    Lam, Tammie
    Min, Amy Cheng
    RETROVIROLOGY, 2022, 19 (01)
  • [33] HIV-1 Integrase Strand Transfer Inhibitors and Neurodevelopment
    Foster, Emma G.
    Gendelman, Howard E.
    Bade, Aditya N.
    PHARMACEUTICALS, 2022, 15 (12)
  • [34] A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection
    Alexa Vyain Zhao
    Rustin D. Crutchley
    Rakesh Chowdary Guduru
    Kathy Ton
    Tammie Lam
    Amy Cheng Min
    Retrovirology, 19
  • [35] Inhibition of matrix metalloproteinases by HIV-1 integrase strand transfer inhibitors
    Foster, Emma G. G.
    Palermo, Nicholas Y. Y.
    Liu, Yutong
    Edagwa, Benson
    Gendelman, Howard E. E.
    Bade, Aditya N. N.
    FRONTIERS IN TOXICOLOGY, 2023, 5
  • [36] The Discovery of Indole-2-carboxylic Acid Derivatives as Novel HIV-1 Integrase Strand Transfer Inhibitors
    Wang, Yu-Chan
    Zhang, Wen-Li
    Zhang, Rong-Hong
    Liu, Chun-Hua
    Zhao, Yong-Long
    Yan, Guo-Yi
    Liao, Shang-Gao
    Li, Yong-Jun
    Zhou, Meng
    MOLECULES, 2023, 28 (24):
  • [37] Short Communication: Integrase Strand Transfer Inhibitors Drug Resistance Mutations in Puerto Rico HIV-Positive Individuals
    Lopez, Pablo
    Tirado, Grissell
    Arias, Andrea
    Sanchez, Raphael
    Rodriguez-Lopez, Elliott R.
    Rivera-Amill, Vanessa
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (05) : 1 - 9
  • [38] Review of integrase strand transfer inhibitors for the treatment of human immunodeficiency virus infection
    Park, Tae Eun
    Mohamed, Abdilahi
    Kalabalik, Julie
    Sharma, Roopali
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2015, 13 (10) : 1195 - 1212
  • [39] Prevalence of Integrase Strand Transfer Inhibitors Resistance Mutations in Integrase Strand Transfer Inhibitors-Naive and -Experienced HIV-1 Infected Patients: A Single Center Experience
    De Francesco, Maria Antonia
    Izzo, Ilaria
    Properzi, Martina
    Gargiulo, Franco
    Caccuri, Francesca
    Quiros-Roldan, Eugenia
    Castelli, Francesco
    Caruso, Arnaldo
    Foca, Emanuele
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 (07) : 570 - 574
  • [40] Dolutegravir: A New Integrase Strand Transfer Inhibitor for the Treatment of HIV
    Shah, Bhavik M.
    Schafer, Jason J.
    DeSimone, Joseph A., Jr.
    PHARMACOTHERAPY, 2014, 34 (05): : 506 - 520
12345